サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1666253

欧州のドライアイ製品市場：2031年までの予測 - 地域別分析 - 製品別、剤形別、タイプ別、流通チャネル別

Europe Dry Eye Products Market Forecast to 2031 - Regional Analysis - by Product, Dosage Form, Type, and Distribution Channel

出版日
ページ情報
英文 110 Pages
納期
即納可能 即納可能とは
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
欧州のドライアイ製品市場：2031年までの予測 - 地域別分析 - 製品別、剤形別、タイプ別、流通チャネル別
出版日: 2025年01月13日
発行: The Insight Partners
ページ情報: 英文 110 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

欧州のドライアイ製品市場は、2023年に16億1,759万米ドルとなり、2031年までには23億1,160万米ドルに達すると予測され、2023年から2031年までのCAGRは4.6%と推定されます。

高齢者人口の増加が欧州のドライアイ製品市場を牽引

ドライアイ症候群は一般的な眼疾患であり、特に50歳以上の高齢者が大きな割合を占めています。コンタクトレンズの使用、自己免疫疾患の流行、全身的な薬物の影響、屈折矯正手術などと関連する可能性があります。ドライアイ症候群の負担は、平均寿命の伸びや高齢者人口の増加により、今後も急増し続けると思われます。世界保健機関（WHO）によると、60歳以上の人口は2020年の10億人から2030年には14億人に増加し、2050年にはさらに倍増して20億人に達すると予想されています。80歳以上の人口は、2020年から2050年にかけて3倍の4億2,600万人に達すると予想されています。このように、人工涙液のようなドライアイ製品の需要は、世界の高齢者人口の増加とともに増加しています。

欧州のドライアイ製品市場概要

欧州のドライアイ製品市場は、ドイツ、英国、フランス、イタリア、スペイン、その他欧州に区分されます。同地域は欧州のドライアイ製品市場で重要な位置を占めており、予測期間中に力強いCAGRを記録することが期待されています。同地域の市場成長の主な要因は、緑内障の罹患率の上昇（ドライアイの症例増加につながります）、新製品の入手可能性、高齢化人口の急増、DEDに対する意識の高まりです。ドイツは眼疾患患者の多い国です。緑内障、白内障、網膜剥離などの眼科疾患が広く発生しているため、同国では点眼薬の重要性が高まっています。ドイツにおける網膜剥離の発生率：2021年5月にOphthalmologicaに発表された"Results from the Gutenberg Health Study"によると、ドイツにおける網膜剥離疾患の発症率は、35歳から74歳の年齢層で年間10万人あたり42人でした。他の欧州諸国の推定と比較すると、ドイツはこの年齢層の網膜剥離の発生率が高いです。

連邦統計局（Destatis）によると、2021年にはドイツで67歳以上の高齢者は1,620万人に達し、2060年には2,160万人に増加すると予測されています。視力障害やその他の病気は高齢者に多いです。高齢化社会では、予測期間中に眼に関連する病気を発症する可能性が高く、それがドイツのドライアイ製品市場の成長を促進しています。

欧州のドライアイ製品市場の収益と2031年までの予測（金額）

欧州のドライアイ製品市場セグメンテーション

欧州のドライアイ製品市場は、製品、剤形、タイプ、流通チャネル、国に分類されます。

製品に基づき、欧州のドライアイ製品市場は人工涙液、抗炎症薬、点鼻プラグ、分泌促進薬、経口オメガサプリメント、その他に区分されます。人工涙液セグメントは2023年に欧州のドライアイ製品市場で最大のシェアを占めました。さらに、抗炎症薬セグメントは、シクロスポリン、コルチコステロイド、その他に細分化されます。さらに、穿刺プラグセグメントは溶解可能なものと取り外し可能なものに細分化されます。

剤形別では、欧州のドライアイ製品市場は点眼薬、ゲル、カプセル・錠剤、その他に区分されます。2023年の欧州のドライアイ製品市場シェアは、点眼薬セグメントが最大でした。

製品タイプ別では、欧州のドライアイ製品市場はOTCと処方箋に二分されます。2023年には、OTCセグメントが欧州のドライアイ製品市場でより大きなシェアを占めました。

流通チャネルに基づくと、欧州のドライアイ製品市場は小売薬局、病院薬局、オンライン薬局に分類されます。小売薬局セグメントは2023年に欧州のドライアイ製品市場で最大のシェアを占めました。

国別では、欧州のドライアイ製品市場はドイツ、英国、フランス、イタリア、スペイン、その他欧州に分類されます。2023年の欧州のドライアイ製品市場シェアはドイツが独占しました。

Santen Pharmaceutical Co Ltd、Johnson &Johnson、OASIS Medical、URSAPHARM Arzneimittel GmbH、Rohto Pharmaceutical Co Ltd、OCuSOFT Inc、Bausch Health Companies Inc、AbbVie Inc、Prestige Consumer Healthcare Inc、Farmigea SpA、Alcon AG.は、欧州のドライアイ製品市場で事業を展開する主要企業です。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

  • 主要な洞察

第3章 調査手法

  • 調査範囲
  • 2次調査
  • 1次調査

第4章 欧州のドライアイ製品市場-主要市場力学

  • 市場促進要因
    • ドライアイの有病率の上昇
    • 高齢者人口
    • 市場抑制要因
      • 点眼薬の副作用と製品回収
    • 市場機会
      • アイケア啓蒙活動の増加
    • 今後の動向
      • ドライアイ治療薬の継続的調査とパイプラインの成長
    • 促進要因と抑制要因の影響

第5章 ドライアイ製品市場：欧州市場分析

  • 欧州のドライアイ製品市場収益、2021年～2031年

第6章 欧州のドライアイ製品市場分析：製品別

  • 人工涙液
  • 抗炎症薬
  • パンクタルプラグ
  • 分泌促進剤
  • 経口オメガサプリメント
  • その他

第7章 欧州のドライアイ製品市場分析：剤形別

  • 点眼薬
  • ジェル
  • カプセル・錠剤
  • その他

第8章 欧州のドライアイ製品市場分析：製品タイプ別

  • 一般用医薬品
  • 処方薬

第9章 欧州のドライアイ製品市場分析：流通チャネル別

  • 小売薬局
  • 病院薬局
  • オンライン薬局

第10章 欧州のドライアイ製品市場：国別分析

  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他欧州

第11章 業界情勢

  • ドライアイ製品市場における成長戦略
  • 有機的成長戦略
  • 無機的成長戦略

第12章 企業プロファイル

  • Santen Pharmaceutical Co Ltd
  • Johnson & Johnson
  • OASIS Medical
  • URSAPHARM Arzneimittel GmbH
  • Rohto Pharmaceutical Co Ltd
  • OCuSOFT Inc.
  • Bausch Health Companies Inc
  • AbbVie Inc
  • Prestige Consumer Healthcare Inc.
  • Farmigea SpA
  • Alcon AG

第13章 付録

図表

List Of Tables

  • Table 1. Europe Dry Eye Products Market Segmentation
  • Table 2. Europe Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million) - by Anti-inflammatory Drugs
  • Table 3. Europe Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million) - by Punctal Plugs
  • Table 4. Germany: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million) - by Product
  • Table 5. Germany: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million) - by Anti-inflammatory Drugs
  • Table 6. Germany: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million) - by Punctal Plugs
  • Table 7. Germany: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million) - by Dosage Form
  • Table 8. Germany: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million) - by Type
  • Table 9. Germany: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million) - by Distribution Channel
  • Table 10. United Kingdom: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million) - by Product
  • Table 11. United Kingdom: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million) - by Anti-inflammatory Drugs
  • Table 12. United Kingdom: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million) - by Punctal Plugs
  • Table 13. United Kingdom: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million) - by Dosage Form
  • Table 14. United Kingdom: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million) - by Type
  • Table 15. United Kingdom: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million) - by Distribution Channel
  • Table 16. France: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million) - by Product
  • Table 17. France: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million) - by Anti-inflammatory Drugs
  • Table 18. France: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million) - by Punctal Plugs
  • Table 19. France: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million) - by Dosage Form
  • Table 20. France: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million) - by Type
  • Table 21. France: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million) - by Distribution Channel
  • Table 22. Italy: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million) - by Product
  • Table 23. Italy: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million) - by Anti-inflammatory Drugs
  • Table 24. Italy: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million) - by Punctal Plugs
  • Table 25. Italy: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million) - by Dosage Form
  • Table 26. Italy: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million) - by Type
  • Table 27. Italy: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million) - by Distribution Channel
  • Table 28. Spain: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million) - by Product
  • Table 29. Spain: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million) - by Anti-inflammatory Drugs
  • Table 30. Spain: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million) - by Punctal Plugs
  • Table 31. Spain: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million) - by Dosage Form
  • Table 32. Spain: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million) - by Type
  • Table 33. Spain: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million) - by Distribution Channel
  • Table 34. Rest of Europe: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million) - by Product
  • Table 35. Rest of Europe: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million) - by Anti-inflammatory Drugs
  • Table 36. Rest of Europe: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million) - by Punctal Plugs
  • Table 37. Rest of Europe: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million) - by Dosage Form
  • Table 38. Rest of Europe: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million) - by Type
  • Table 39. Rest of Europe: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million) - by Distribution Channel
  • Table 40. Recent Organic Growth Strategies in the Dry Eye Products Market
  • Table 41. Recent Inorganic Growth Strategies in the Dry Eye Products Market
  • Table 42. Glossary of Terms

List Of Figures

  • Figure 1. Europe Dry Eye Products Market Segmentation, by Country
  • Figure 2. Impact Analysis of Drivers and Restraints
  • Figure 3. Europe Dry Eye Products Market Revenue (US$ Million), 2021-2031
  • Figure 4. Dry Eye Products Market Share (%) - by Product (2023 and 2031)
  • Figure 5. Artificial Tears: Europe Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 6. Anti-Inflammatory Drugs: Europe Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 7. Punctal Plugs: Europe Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 8. Secretagogues: Europe Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 9. Oral Omega Supplements: Europe Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 10. Others: Europe Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 11. Europe Dry Eye Products Market Share (%) - by Dosage Form (2023 and 2031)
  • Figure 12. Eye Drops: Europe Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 13. Gels: Europe Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 14. Capsules and Tablets: Europe Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 15. Others: Europe Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 16. Dry Eye Products Market Share (%) - by Type (2023 and 2031)
  • Figure 17. OTC: Europe Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 18. Prescription: Europe Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 19. Dry Eye Products Market Share (%) - by Distribution Channel (2023 and 2031)
  • Figure 20. Retail Pharmacies: Europe Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 21. Hospital Pharmacies: Europe Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 22. Online Pharmacies: Europe Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 23. Europe: Dry Eye Products Market, by Key Country - Revenue (2023) (US$ Million)
  • Figure 24. Europe: Dry Eye Products Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 25. Germany: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 26. United Kingdom: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 27. France: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 28. Italy: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 29. Spain: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 30. Rest of Europe: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 31. Growth Strategies in the Dry Eye Products Market
目次
Product Code: TIPRE00028853

The Europe dry eye products market was valued at US$ 1,617.59 million in 2023 and is expected to reach US$ 2,311.60 million by 2031; it is estimated to register a CAGR of 4.6% from 2023 to 2031.

Upsurge in Geriatric Population Drives Europe Dry Eye Products Market

Dry eye syndrome is a common eye disorder affecting a substantial share of the population, especially those older than 50. Middle-aged and older adults are more common targets of this syndrome, which can be associated with the usage of contact lenses, the prevalence of autoimmune diseases, systemic drug effects, and refractive surgeries. The burden of dry eye syndrome would continue to surge due to increased life expectancy, along with the rising cases among the elderly population. According to the World Health Organization (WHO), the population aged 60 and above would increase from 1 billion in 2020 to 1.4 billion by 2030; the number is further likely to double and reach ~2 billion by 2050. The number of individuals aged 80 and above is expected to triple from 2020 to 2050 to reach 426 million. Thus, the demand for dry eye products such as artificial tears is increasing with the growing geriatric population worldwide.

Europe Dry Eye Products Market Overview

The Europe dry eye products market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. The region occupies a significant position in the Europe dry eye products market and is expected to record a strong CAGR during the forecast period. The market growth in the region is mainly attributed to rising incidences of glaucoma (leading to the growing cases of dry eye condition), availability of new products, the surging aging population, and rising awareness about DED. Germany is a country with a large number of patients living with eye disorders. Due to the widespread occurrence of ophthalmic conditions such as glaucoma, cataracts, and retinal detachments, eye drops have become increasingly important in the country. According to the "Incidence of Retinal Detachment in Germany: Results from the Gutenberg Health Study," published in Ophthalmologica in May 2021, the incidence of retinal detachment disease in Germany was 42 per 100,000 people per year in the age group of 35-74. Compared to estimates from other European nations, Germany has a high incidence of retinal detachment in people from this age group.

According to the Federal Statistical Office (Destatis), in 2021, ~16.2 million people in Germany aged 67 or more, and the number is projected to rise to 21.6 million by 2060. Eyesight problems and other illnesses are more common among older people. The aging population is more likely to develop eye-related diseases during the projected period, thereby driving the growth of the dry eye products market in Germany.

Europe Dry Eye Products Market Revenue and Forecast to 2031 (US$ Million)

Europe Dry Eye Products Market Segmentation

The Europe dry eye products market is categorized into product, dosage form, type, distribution channel, and country.

Based on product, the Europe dry eye products market is segmented into artificial tears, anti-inflammatory drugs, punctal plugs, secretagogues, oral omega supplements, and others. The artificial tears segment held the largest Europe dry eye products market share in 2023. Furthermore, the anti-inflammatory drugs segment is subcategorized into cyclosporine, corticosteroid, and others. Additionally, the punctal plugs segment is subsegmented into dissolvable and removable.

In terms of dosage form, the Europe dry eye products market is segmented into eye drops, gel, capsules and tablets, and others. The eye drops segment held the largest Europe dry eye products market share in 2023.

By type, the Europe dry eye products market is bifurcated into OTC and prescription. The OTC segment held a larger Europe dry eye products market share in 2023.

Based on distribution channel, the Europe dry eye products market is categorized into retail pharmacy, hospital pharmacy, and online pharmacy. The retail pharmacy segment held the largest Europe dry eye products market share in 2023.

Based on country, the Europe dry eye products market is categorized into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Germany dominated the Europe dry eye products market share in 2023.

Santen Pharmaceutical Co Ltd, Johnson & Johnson, OASIS Medical, URSAPHARM Arzneimittel GmbH, Rohto Pharmaceutical Co Ltd, OCuSOFT Inc, Bausch Health Companies Inc, AbbVie Inc, Prestige Consumer Healthcare Inc, Farmigea SpA, and Alcon AG. are some of the leading companies operating in the Europe dry eye products market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Europe Dry Eye Products Market - Key Market Dynamics

  • 4.1 Market Drivers
    • 4.1.1 Rising Prevalence of Dry Eye
    • 4.1.2 Upsurge in Geriatric Population
  • 4.2 Market Restraints
    • 4.2.1 Side Effects of Eye Drops and Product Recalls
  • 4.3 Market Opportunities
    • 4.3.1 Increasing Initiatives for Eye Care Awareness
  • 4.4 Future Trends
    • 4.4.1 Ongoing Research and Growing Pipeline for Dry Eye Products
  • 4.5 Impact of Drivers and Restraints:

5. Dry Eye Products Market - Europe Market Analysis

  • 5.1 Europe Dry Eye Products Market Revenue (US$ Million), 2021-2031

6. Europe Dry Eye Products Market Analysis - by Product

  • 6.1 Overview
  • 6.2 Artificial Tears
    • 6.2.1 Overview
    • 6.2.2 Artificial Tears: Europe Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
  • 6.3 Anti-Inflammatory Drugs
    • 6.3.1 Overview
    • 6.3.2 Anti-Inflammatory Drugs: Europe Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
      • 6.3.2.1 Europe Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million) - by Anti-inflammatory Drugs
  • 6.4 Punctal Plugs
    • 6.4.1 Overview
    • 6.4.2 Punctal Plugs: Europe Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
      • 6.4.2.1 Europe Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million) - by Punctal Plugs
  • 6.5 Secretagogues
    • 6.5.1 Overview
    • 6.5.2 Secretagogues: Europe Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
  • 6.6 Oral Omega Supplements
    • 6.6.1 Overview
    • 6.6.2 Oral Omega Supplements: Europe Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
  • 6.7 Others
    • 6.7.1 Overview
    • 6.7.2 Others: Europe Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)

7. Europe Dry Eye Products Market Analysis - by Dosage Form

  • 7.1 Overview
  • 7.2 Eye Drops
    • 7.2.1 Overview
    • 7.2.2 Eye Drops: Europe Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.3 Gels
    • 7.3.1 Overview
    • 7.3.2 Gels: Europe Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.4 Capsules and Tablets
    • 7.4.1 Overview
    • 7.4.2 Capsules and Tablets: Europe Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.5 Others
    • 7.5.1 Overview
    • 7.5.2 Others: Europe Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)

8. Europe Dry Eye Products Market Analysis - by Type

  • 8.1 Overview
  • 8.2 OTC
    • 8.2.1 Overview
    • 8.2.2 OTC: Europe Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.3 Prescription
    • 8.3.1 Overview
    • 8.3.2 Prescription: Europe Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)

9. Europe Dry Eye Products Market Analysis - by Distribution Channel

  • 9.1 Overview
  • 9.2 Retail Pharmacies
    • 9.2.1 Overview
    • 9.2.2 Retail Pharmacies: Europe Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.3 Hospital Pharmacies
    • 9.3.1 Overview
    • 9.3.2 Hospital Pharmacies: Europe Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.4 Online Pharmacies
    • 9.4.1 Overview
    • 9.4.2 Online Pharmacies: Europe Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)

10. Europe Dry Eye Products Market - Country Analysis

  • 10.1 Europe: Dry Eye Products Market
    • 10.1.1 Europe: Dry Eye Products Market - Revenue and Forecast Analysis - by Country
      • 10.1.1.1 Germany: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.1.1.1.1 Germany: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.1.1.1.2 Germany: Dry Eye Products Market Breakdown, by Product
        • 10.1.1.1.2.1 Germany: Dry Eye Products Market Breakdown, by Anti-inflammatory Drugs
        • 10.1.1.1.2.2 Germany: Dry Eye Products Market Breakdown, by Punctal Plugs
        • 10.1.1.1.3 Germany: Dry Eye Products Market Breakdown, by Dosage Form
        • 10.1.1.1.4 Germany: Dry Eye Products Market Breakdown, by Type
        • 10.1.1.1.5 Germany: Dry Eye Products Market Breakdown, by Distribution Channel
      • 10.1.1.2 United Kingdom: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.1.1.2.1 Overview
        • 10.1.1.2.2 United Kingdom: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.1.1.2.3 United Kingdom: Dry Eye Products Market Breakdown, by Product
        • 10.1.1.2.3.1 United Kingdom: Dry Eye Products Market Breakdown, by Anti-inflammatory Drugs
        • 10.1.1.2.3.2 United Kingdom: Dry Eye Products Market Breakdown, by Punctal Plugs
        • 10.1.1.2.4 United Kingdom: Dry Eye Products Market Breakdown, by Dosage Form
        • 10.1.1.2.5 United Kingdom: Dry Eye Products Market Breakdown, by Type
        • 10.1.1.2.6 United Kingdom: Dry Eye Products Market Breakdown, by Distribution Channel
      • 10.1.1.3 France: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.1.1.3.1 Overview
        • 10.1.1.3.2 France: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.1.1.3.3 France: Dry Eye Products Market Breakdown, by Product
        • 10.1.1.3.3.1 France: Dry Eye Products Market Breakdown, by Anti-inflammatory Drugs
        • 10.1.1.3.3.2 France: Dry Eye Products Market Breakdown, by Punctal Plugs
        • 10.1.1.3.4 France: Dry Eye Products Market Breakdown, by Dosage Form
        • 10.1.1.3.5 France: Dry Eye Products Market Breakdown, by Type
        • 10.1.1.3.6 France: Dry Eye Products Market Breakdown, by Distribution Channel
      • 10.1.1.4 Italy: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.1.1.4.1 Overview
        • 10.1.1.4.2 Italy: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.1.1.4.3 Italy: Dry Eye Products Market Breakdown, by Product
        • 10.1.1.4.3.1 Italy: Dry Eye Products Market Breakdown, by Anti-inflammatory Drugs
        • 10.1.1.4.3.2 Italy: Dry Eye Products Market Breakdown, by Punctal Plugs
        • 10.1.1.4.4 Italy: Dry Eye Products Market Breakdown, by Dosage Form
        • 10.1.1.4.5 Italy: Dry Eye Products Market Breakdown, by Type
        • 10.1.1.4.6 Italy: Dry Eye Products Market Breakdown, by Distribution Channel
      • 10.1.1.5 Spain: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.1.1.5.1 Overview
        • 10.1.1.5.2 Spain: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.1.1.5.3 Spain: Dry Eye Products Market Breakdown, by Product
        • 10.1.1.5.3.1 Spain: Dry Eye Products Market Breakdown, by Anti-inflammatory Drugs
        • 10.1.1.5.3.2 Spain: Dry Eye Products Market Breakdown, by Punctal Plugs
        • 10.1.1.5.4 Spain: Dry Eye Products Market Breakdown, by Dosage Form
        • 10.1.1.5.5 Spain: Dry Eye Products Market Breakdown, by Type
        • 10.1.1.5.6 Spain: Dry Eye Products Market Breakdown, by Distribution Channel
      • 10.1.1.6 Rest of Europe: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.1.1.6.1 Overview
        • 10.1.1.6.2 Rest of Europe: Dry Eye Products Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.1.1.6.3 Rest of Europe: Dry Eye Products Market Breakdown, by Product
        • 10.1.1.6.3.1 Rest of Europe: Dry Eye Products Market Breakdown, by Anti-inflammatory Drugs
        • 10.1.1.6.3.2 Rest of Europe: Dry Eye Products Market Breakdown, by Punctal Plugs
        • 10.1.1.6.4 Rest of Europe: Dry Eye Products Market Breakdown, by Dosage Form
        • 10.1.1.6.5 Rest of Europe: Dry Eye Products Market Breakdown, by Type
        • 10.1.1.6.6 Rest of Europe: Dry Eye Products Market Breakdown, by Distribution Channel

11. Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in the Dry Eye Products Market
  • 11.3 Organic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Inorganic Growth Strategies
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 Santen Pharmaceutical Co Ltd
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Johnson & Johnson
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 OASIS Medical
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 URSAPHARM Arzneimittel GmbH
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Rohto Pharmaceutical Co Ltd
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 OCuSOFT Inc.
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Bausch Health Companies Inc
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 AbbVie Inc
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 Prestige Consumer Healthcare Inc.
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments
  • 12.10 Farmigea SpA
    • 12.10.1 Key Facts
    • 12.10.2 Business Description
    • 12.10.3 Products and Services
    • 12.10.4 Financial Overview
    • 12.10.5 SWOT Analysis
    • 12.10.6 Key Developments
  • 12.11 Alcon AG
    • 12.11.1 Key Facts
    • 12.11.2 Business Description
    • 12.11.3 Products and Services
    • 12.11.4 Financial Overview
    • 12.11.5 SWOT Analysis
    • 12.11.6 Key Developments

13. Appendix

  • 13.1 About The Insight Partners
  • 13.2 Glossary of Terms